nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
A new intracellular targeting motif in the cytoplasmic tail of the spike protein may act as a target to inhibit SARS-CoV-2 assembly
|
Hu, Longbo |
|
|
209 |
C |
p. |
artikel |
2 |
A stable hepatitis D virus-producing cell line for host target and drug discovery
|
Bach, Charlotte |
|
|
209 |
C |
p. |
artikel |
3 |
Ciliatoside A, isolated from Peristrophe japonica, inhibits HBsAg expression and cccDNA transcription by inducing autophagy
|
Fang, Ren |
|
|
209 |
C |
p. |
artikel |
4 |
Design and synthesis of a new series of hybrids of functionalised N 1-[(1H-1,2,3-triazol-4-yl)methyl]quinazoline-2,4-dione with antiviral activity against Respiratory Syncytial Virus
|
Głowacka, Iwona E. |
|
|
209 |
C |
p. |
artikel |
5 |
Discovery of lead natural products for developing pan-SARS-CoV-2 therapeutics
|
Pérez-Vargas, Jimena |
|
|
209 |
C |
p. |
artikel |
6 |
Editorial Board
|
|
|
|
209 |
C |
p. |
artikel |
7 |
Evaluation of molnupiravir (EIDD-2801) efficacy against SARS-CoV-2 in the rhesus macaque model
|
Johnson, Dylan M. |
|
|
209 |
C |
p. |
artikel |
8 |
Functional characterization and immunogenicity of a novel vaccine candidate against tick-borne encephalitis virus based on Leishmania-derived virus-like particles
|
Zimna, Marta |
|
|
209 |
C |
p. |
artikel |
9 |
Hepatitis D virus: Improving virological knowledge to develop new treatments
|
Khalfi, Pierre |
|
|
209 |
C |
p. |
artikel |
10 |
Implications of the antiviral drug favipiravir on rabies immunoglobulin for post-exposure prophylaxis of rabies in mice model with category III-like exposures
|
Kimitsuki, Kazunori |
|
|
209 |
C |
p. |
artikel |
11 |
Induction of a strong and long-lasting neutralizing immune response by dPreS1-TLR2 agonist nanovaccine against hepatitis B virus
|
Lamrayah, Myriam |
|
|
209 |
C |
p. |
artikel |
12 |
Inhibition of p38 signaling curtails the SARS-CoV-2 induced inflammatory response but retains the IFN-dependent antiviral defense of the lung epithelial barrier
|
Faist, Aileen |
|
|
209 |
C |
p. |
artikel |
13 |
Intranasal delivery of replicating mRNA encoding hACE2-targeting antibody against SARS-CoV-2 Omicron infection in the hamster
|
Zhang, Ya-Nan |
|
|
209 |
C |
p. |
artikel |
14 |
Investigating N-arylpyrimidinamine (NAPA) compounds as early-stage inhibitors against human cytomegalovirus
|
Parsons, Andrea J. |
|
|
209 |
C |
p. |
artikel |
15 |
In vitro and in vivo effects of 3-indoleacetonitrile—A potential new broad-spectrum therapeutic agent for SARS-CoV-2 infection
|
Hui, Xianfeng |
|
|
209 |
C |
p. |
artikel |
16 |
ML390 inhibits enterovirus 71 replication by targeting de novo pyrimidine biosynthesis pathway
|
Yang, Qingyu |
|
|
209 |
C |
p. |
artikel |
17 |
Multiplication of defective Ebola virus in a complementary permissive cell line
|
Tong, Xian-Kun |
|
|
209 |
C |
p. |
artikel |
18 |
5-(Perylen-3-ylethynyl)uracil as an antiviral scaffold: Potent suppression of enveloped virus reproduction by 3-methyl derivatives in vitro
|
Chistov, Alexey A. |
|
|
209 |
C |
p. |
artikel |
19 |
Phenothiazines inhibit SARS-CoV-2 cell entry via a blockade of spike protein binding to neuropilin-1
|
Hashizume, Mei |
|
|
209 |
C |
p. |
artikel |
20 |
PI3K/AKT-mediated autophagy inhibition facilitates mast cell activation to enhance severe inflammatory lung injury in influenza A virus- and secondary Staphylococcus aureus-infected mice
|
Tang, Yuling |
|
|
209 |
C |
p. |
artikel |
21 |
Preclinical characterization of ABI-H2158, an HBV core inhibitor with dual mechanisms of action
|
Yan, Ran |
|
|
209 |
C |
p. |
artikel |
22 |
Rapid discovery and classification of inhibitors of coronavirus infection by pseudovirus screen and amplified luminescence proximity homogeneous assay
|
Jeong, Kwiwan |
|
|
209 |
C |
p. |
artikel |
23 |
RBM24 inhibits the translation of SARS-CoV-2 polyproteins by targeting the 5ʹ-untranslated region
|
Yao, Yongxuan |
|
|
209 |
C |
p. |
artikel |
24 |
Targeting 7-dehydrocholesterol reductase against EV-A71 replication by upregulating interferon response
|
Wang, Huiqiang |
|
|
209 |
C |
p. |
artikel |
25 |
The life cycle of the alphaviruses: From an antiviral perspective
|
Skidmore, Andrew M. |
|
|
209 |
C |
p. |
artikel |
26 |
The prophylactic and therapeutic efficacy of the broadly active antiviral ribonucleoside N 4 -Hydroxycytidine (EIDD-1931) in a mouse model of lethal Ebola virus infection
|
Bluemling, Gregory R. |
|
|
209 |
C |
p. |
artikel |
27 |
Therapeutic targeting of organelles for inhibition of Zika virus replication in neurons
|
Ojha, Durbadal |
|
|
209 |
C |
p. |
artikel |
28 |
Tissue replication and mucosal swab detection of Sosuga virus in Syrian hamsters in the absence of overt tissue pathology and clinical disease
|
Welch, Stephen R. |
|
|
209 |
C |
p. |
artikel |